4D Molecular Therapeutics (FDMT) Other Non Operating Income: 2020-2025
Historic Other Non Operating Income for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Sep 2025 value amounting to -$21,000.
- 4D Molecular Therapeutics' Other Non Operating Income fell 2000.00% to -$21,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$36,000, marking a year-over-year increase of 46.27%. This contributed to the annual value of -$77,000 for FY2024, which is 57.46% up from last year.
- As of Q3 2025, 4D Molecular Therapeutics' Other Non Operating Income stood at -$21,000, which was up 65.57% from -$61,000 recorded in Q2 2025.
- Over the past 5 years, 4D Molecular Therapeutics' Other Non Operating Income peaked at $67,000 during Q1 2025, and registered a low of -$158,000 during Q3 2023.
- Over the past 3 years, 4D Molecular Therapeutics' median Other Non Operating Income value was -$19,000 (recorded in 2023), while the average stood at -$24,727.
- Over the last 5 years, 4D Molecular Therapeutics' Other Non Operating Income had its largest YoY gain of 770.00% in 2025, and its largest YoY loss of 2,000.00% in 2025.
- Over the past 5 years, 4D Molecular Therapeutics' Other Non Operating Income (Quarterly) stood at -$7,000 in 2021, then soared by 142.86% to $3,000 in 2022, then plummeted by 466.67% to -$11,000 in 2023, then slumped by 90.91% to -$21,000 in 2024, then slumped by 2,000.00% to -$21,000 in 2025.
- Its Other Non Operating Income stands at -$21,000 for Q3 2025, versus -$61,000 for Q2 2025 and $67,000 for Q1 2025.